NYSE Euronext Announces Trading Volumes for December 2011 and Other Metrics

Global Derivatives ADV Up 12% Year-over-Year; U.S. Equity Options ADV Up 17%

NYSE Liffe U.S. Crosses One Million Contracts in Total Exchange Open Interest

European Cash ADV Up 9%; U.S. Cash ADV Down 11%

NEW YORK--(BUSINESS WIRE)--NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for December 2011¹. Global derivatives average daily volume (“ADV”) of 7.5 million contracts in December 2011 increased 11.8% versus the prior year with U.S. equity options increasing 17.1%. Cash equities ADV in December 2011 were mixed, with European cash trading ADV increasing 9.0% and U.S. cash trading ADV decreasing 10.6% from December 2010 levels.

Highlights

• NYSE Euronext global derivatives ADV in December 2011 of 7.5 million contracts increased 11.8% compared to December 2010, but decreased 10.1% from November 2011 levels.
• NYSE Euronext European derivatives products ADV in December 2011 of 3.4 million contracts increased 4.2% compared to December 2010, but decreased 13.4% from November 2011 levels. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 8.3% compared to December 2010 and decreased 29.5% from November 2011.
• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.9 million contracts in December 2011 increased 17.1% compared to December 2010 levels, but decreased 7.3% from November 2011. NYSE Euronext’s U.S. options exchanges accounted for 27.7% of total U.S. consolidated equity options trading in December 2011, up from 23.1% in December 2010, but down from a record 28.1% in November 2011.
• NYSE Liffe U.S. ADV of approximately 89,600 contracts increased from 13,000 contracts in December 2010 and increased from 88,500 contracts in November 2011.
• NYSE Liffe U.S. reached one million lots in total Exchange Open Interest in December 2011, less than one year after introducing its suite of interest rate futures contracts, underscoring the liquidity across asset classes and continued high levels of customer participation. Open interest market share in Eurodollar futures represented 10% of open interest traded on our nearest competitor.
• NYSE Euronext European cash products ADV of 1.3 million transactions in December 2011 increased 9.0% compared to December 2010, but decreased 19.9% from November 2011 levels.
• NYSE Euronext U.S. cash products (NYSE, NYSE Arca and NYSE Amex) handled ADV of 1.8 billion shares in December 2011 decreased 10.6% compared to December 2010 and decreased 14.9% compared to November 2011. NYSE Euronext’s Tape A matched market share in December 2011 was 33.4%, down from 35.0% in December 2010 and down from 34.1% in November 2011.
• There were a total of 21 trading days in Europe and the U.S. in December 2011 compared to 23 trading days in Europe and 22 trading days in the U.S. in December 2010.
• The preliminary average net revenue per transaction type (as defined below) for each of the primary trading venues in the fourth quarter of 2011 is included below:

	3Q11 Actual	4Q11 Preliminary
European Derivatives (ex. Bclear)^1	$0.679	$0.698
U.S. Derivatives^2	$0.154	$0.148
European Cash^3	$0.635	$0.579
U.S. Cash^4	$0.038	$0.039
^1Average net revenue per contract, excluding Bclear.
^2Average net revenue per contract.
^3Average net revenue per transaction.
^4Average net revenue per 100 shares handled.

Derivatives Trading

European Derivatives

• NYSE Euronext European derivatives products ADV in December 2011 was 3.4 million futures and options contracts, an increase of 4.2% from December 2010, but a decrease of 13.4% from November 2011.
• The 3.4 million in European derivatives futures and options contracts ADV in December 2011 consisted of 2.2 million contracts executed through our full-service LIFFE CONNECT trading platform and 1.2 million contracts, or 36.0%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Excluding Bclear, European derivatives products ADV decreased 8.3% compared to December 2010 and decreased 29.5% from November 2011.
• In the fourth quarter of 2011, European derivatives products ADV of 3.6 million contracts was 3.3% below prior year levels. The 3.6 million in futures and options contracts ADV in the fourth quarter of 2011 consisted of 2.7 million contracts executed through LIFFE CONNECT trading platform and 0.9 million contracts, or 24.0%, executed through Bclear. Excluding Bclear, European derivatives products ADV in the fourth quarter of 2011 decreased 4.5% compared to the prior year period.
• For the full-year 2011, European derivatives products ADV of 4.5 million contracts was 5.7% below prior year levels. The 4.5 million in futures and options contracts ADV For the full-year 2011 consisted of 3.3 million contracts executed through the LIFFE CONNECT trading platform and 1.1 million contracts, or 25.5%, executed through Bclear.
• Total fixed income products ADV of 1.4 million contracts in December 2011 decreased 8.2% from December 2010 and decreased 36.7% from November 2011. In the fourth quarter of 2011, total fixed income products ADV of 1.8 million contracts was 0.9% below prior year levels. For the full-year 2011, total fixed income products ADV of 2.3 million contracts was 1.2% below prior year levels.
• Total equity products (including Bclear) ADV of 2.0 million contracts in December 2011 increased 14.4% compared to December 2010 and increased 14.2% from November 2011. The 2.0 million contracts in equity products ADV consisted of 1.5 million contracts in individual equity products ADV and 0.5 million contracts in equity index products ADV. The 1.5 million contracts in individual equity products ADV consisted of 1.1 million in futures contracts, which represented a 43.8% increase compared to December 2010 and 0.5 million in options contracts, which represented a 15.2% decrease compared to December 2010. The average net rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. In the fourth quarter of 2011, total equity products ADV of 1.7 million contracts was 5.9% below prior year levels. For the full-year 2011, total equity products ADV of 2.1 million contracts was 10.8% below prior year levels.
• Total commodities products ADV of 68,000 contracts in December 2011 increased 6.4% compared to December 2010 and was down 0.9% compared to November 2011. In the fourth quarter of 2011, total commodities product ADV of 72,000 contracts was 4.2% above prior year levels. For the full-year 2011, total commodities product ADV of 81,000 contracts was 24.8% above prior year levels.

U.S. Derivatives

• NYSE Euronext U.S. equity options (NYSE Arca and NYSE Amex) ADV of 3.9 million contracts in December 2011 increased 17.1% compared to December 2010, but decreased 7.3% compared to November 2011. In the fourth quarter of 2011, U.S. equity options ADV of 4.3 million contracts was 15.4% above prior year levels. For the full-year 2011, U.S. equity options ADV of 4.4 million contracts was 20.0% above prior year levels.
• Total U.S. consolidated equity options ADV decreased 2.4% to 14.2 million contracts in December 2011 compared to December 2010 and decreased 5.9% compared to November 2011. In the fourth quarter of 2011, U.S. consolidated equity options ADV of 15.5 million contracts was 2.4% above prior year levels. For the full-year 2011, U.S. consolidated equity options ADV of 16.8 million contracts was 17.0% above prior year levels.
• NYSE Euronext’s U.S. options exchanges accounted for 27.7% of the total U.S. consolidated equity options trading in December 2011, up from 23.1% in December 2010, but down from a record 28.1% in November 2011.
• NYSE Liffe U.S. ADV of approximately 89,600 contracts increased from 13,000 contracts in December 2010 and increased from 88,500 contracts in November 2011. In the fourth quarter of 2011, U.S. futures and futures options ADV was 91,200 contracts compared to 14,900 contracts in the prior year quarter. For the full-year 2011, U.S. futures and futures options ADV of 81,200 contracts was 401.3% above prior year levels, driven by the launch of interest rate futures contracts in March 2011.
• NYSE Liffe U.S. reached one million lots in total Exchange Open Interest in December 2011, less than one year after introducing its suite of interest rate futures contracts, underscoring the liquidity across asset classes and continued high levels of customer participation. Open interest market share in Eurodollar futures represented 10% of open interest traded on our nearest competitor.

Cash Trading

European Cash

• NYSE Euronext European cash products ADV of 1.3 million transactions in December 2011 increased 9.0% compared to December 2010, but decreased 19.9% compared to November 2011.
• In the fourth quarter of 2011, European cash products ADV of 1.6 million transactions was 13.2% above prior year levels.
• For the full-year 2011, European cash products ADV of 1.7 million transactions was 17.1% above prior year levels.

U.S. Cash

• NYSE Euronext U.S. cash products handled ADV in December 2011 decreased 10.6% to 1.8 billion shares compared to December 2010 and decreased 14.9% from November 2011.
• In the fourth quarter of 2011, U.S. cash products handled ADV was 2.1 billion shares, down 4.5% from prior year levels.
• For the full-year 2011, U.S. cash products handled ADV was 2.3 billion shares, down 12.1% from prior year levels.
• NYSE Euronext’s Tape A matched market share in December 2011 was 33.4%, down from 35.0% in December 2010 and down from 34.1% in November 2011.

Exchange Traded Funds

• NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 248 million shares in December 2011 increased 15.7% compared to December 2010, but decreased 22.7% compared to November 2011.
• In the fourth quarter of 2011, NYSE Euronext U.S. matched exchange-traded funds ADV of 323 million shares was 16.9% above prior year levels.
• For the full-year 2011, NYSE Euronext U.S. matched exchange-traded funds ADV of 324 million shares was 2.6% below prior year levels.

Other Metrics

• On December 22, 2011, BlueNext S.A., a joint venture with Caisse des Dépôts, reached a settlement with the French tax authorities regarding its liability arising from a tax audit for the period January 2006 through May 2009. The settlement amount, including penalties, is €31.8 million. NYSE Euronext will record its 60% share of the joint venture's settlement amount during the quarter ending December 31, 2011 as a non-recurring charge.
• The average EUR/USD exchange rate for the fourth quarter of 2011 of $1.35 represented a decrease of 4.6% from the third quarter of 2011 and a decrease of 0.8% compared to the fourth quarter of 2010.
• The average GBP/USD exchange rate for the fourth quarter of 2011 of $1.57 represented a decrease of 2.4% from the third quarter of 2011 and a decrease of 0.5% compared to the third quarter of 2010.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.

Safe Harbour Statement

In connection with the proposed business combination transaction between NYSE Euronext and Deutsche Boerse AG, Alpha Beta Netherlands Holding N.V. (“Holding”), a newly formed holding company, filed, and the SEC declared effective on May 3, 2011, a Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission (“SEC”) that includes (1) a proxy statement of NYSE Euronext that also constitutes a prospectus for Holding used in connection with NYSE Euronext special meeting of stockholders held on July 7, 2011 and (2) an offering prospectus used in connection with Holding’s offer to acquire Deutsche Boerse AG shares held by U.S. holders. Holding has also filed an offer document with the German Federal Financial Supervisory Authority (Bundesanstalt fuer Finanzdienstleistungsaufsicht) (“BaFin”), which was approved by the BaFin for publication pursuant to the German Takeover Act (Wertpapiererwerbs-und Übernahmegesetz), and was published on May 4, 2011.

Investors and security holders are urged to read the definitive proxy statement/prospectus, the offering prospectus, the offer document, as amended, and published additional accompanying information in connection with the exchange offer regarding the proposed business combination transaction because they contain important information. You may obtain a free copy of the definitive proxy statement/prospectus, the offering prospectus and other related documents filed by NYSE Euronext and Holding with the SEC on the SEC’s website at www.sec.gov. The definitive proxy statement/prospectus and other documents relating thereto may also be obtained for free by accessing NYSE Euronext’s website at www.nyse.com. The offer document, as amended, and published additional accompanying information in connection with the exchange offer are available at Holding’s website at www.global-exchange-operator.com.

This document is neither an offer to purchase nor a solicitation of an offer to sell shares of Holding, Deutsche Boerse AG or NYSE Euronext. The final terms and further provisions regarding the public offer are disclosed in the offer document that has been approved by the BaFin and in documents that have been filed with the SEC.

No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended, and applicable European regulations. The exchange offer and the exchange offer document as amended, shall not constitute an issuance, publication or public advertising of an offer pursuant to laws and regulations of jurisdictions other than those of Germany, United Kingdom of Great Britain and Northern Ireland and the United States of America. The relevant final terms of the proposed business combination transaction will be disclosed in the information documents reviewed by the competent European market authorities.

Subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the exchange offer will not be made directly or indirectly in or into Japan, or by use of the mails or by any means or instrumentality (including without limitation, facsimile transmission, telephone and the internet) of interstate or foreign commerce or any facility of a national securities exchange of Japan. Accordingly, copies of this announcement or any accompanying documents may not be, directly or indirectly, mailed or otherwise distributed, forwarded or transmitted in, into or from Japan.

The shares of Holding have not been, and will not be, registered under the applicable securities laws of Japan. Accordingly, subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the shares of Holding may not be offered or sold within Japan, or to or for the account or benefit of any person in Japan.

Forward-Looking Statements

This document includes forward-looking statements. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance and actual results of operations, financial condition and liquidity, and the development of the industries in which NYSE Euronext operates may differ materially from those made in or suggested by the forward-looking statements contained in this document. Any forward-looking statements speak only as at the date of this document. Except as required by applicable law, NYSE Euronext does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

¹ All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

NYSE Euronext
Monthly Volume Summary
	Average Daily Volume			Total Volume			Average Daily Volume		Total Volume
(Unaudited; contracts in thousands)	Dec-11	Dec-10	% Chg	Dec-11	Dec-10	% Chg	YTD 2011	% Chg vs. YTD 2010	YTD 2011	% Chg vs. YTD 2010
Number of Trading Days - European Markets	21	23		21	23		257		257
Number of Trading Days - U.S. Markets	21	22		21	22		252		252
European Derivatives Products	3,440	3,302	4.2%	72,245	75,957	-4.9%	4,469	-5.7%	1,148,498	-6.1%
of which Bclear	1,240	903	37.4%	26,046	20,759	25.5%	1,141	-13.6%	293,243	-14.0%
Total Fixed Income Products	1,352	1,473	-8.2%	28,390	33,877	-16.2%	2,250	-1.2%	578,255	-1.6%
Short Term Interest Rate Products	1,268	1,396	-9.2%	26,625	32,108	-17.1%	2,111	-2.3%	542,541	-2.7%
Medium and Long Term Interest Rate Products^1	84	77	9.4%	1,766	1,769	-0.1%	139	18.2%	35,714	17.8%
Total Equity Products^2	2,021	1,766	14.4%	42,432	40,616	4.5%	2,138	-10.8%	549,513	-11.1%
Individual Equity Products	1,529	1,292	18.3%	32,109	29,725	8.0%	1,560	-13.3%	401,004	-13.7%
Futures	1,056	734	43.8%	22,168	16,883	31.3%	974	-13.1%	250,442	-13.4%
Options	473	558	-15.2%	9,941	12,841	-22.6%	586	-13.7%	150,562	-14.1%
Equity Index Products	492	474	3.8%	10,323	10,892	-5.2%	578	-3.0%	148,509	-3.4%
of which Bclear	1,240	903	37.4%	26,046	20,759	25.5%	1,141	-13.6%	293,243	-14.0%
Individual Equity Products	1,142	809	41.1%	23,986	18,617	28.8%	1,060	-13.6%	272,384	-14.0%
Futures	1,055	733	43.9%	22,165	16,867	31.4%	959	-14.2%	246,425	-14.5%
Options	87	76	13.9%	1,820	1,750	4.0%	101	-8.0%	25,959	-8.4%
Equity Index Products	98	93	5.3%	2,060	2,142	-3.8%	81	-13.8%	20,858	-14.2%
Commodity Products	68	64	6.4%	1,422	1,464	-2.8%	81	24.8%	20,730	24.3%
U.S. Derivatives Products
Equity Options^3
NYSE Euronext Options Contracts	3,936	3,360	17.1%	82,656	73,926	11.8%	4,406	20.0%	1,110,193	20.0%
Total Consolidated Options Contracts	14,224	14,567	-2.4%	298,702	320,466	-6.8%	16,764	17.0%	4,224,605	17.0%
NYSE Group Share of Total	27.7%	23.1%		27.7%	23.1%		26.3%	0.7%	26.3%	0.7%
NYSE Liffe U.S.
Futures and Futures Options Volume*	89.6	13.0	588.7%	1,882	286	557.4%	81.2	401.3%	20,937.6	413.3%
European Cash Products (trades in thousands)	1,338	1,228	9.0%	28,095	28,235	-0.5%	1,711	17.1%	439,717	16.6%
Equities	1,287	1,177	9.3%	27,023	27,079	-0.2%	1,644	17.2%	422,517	16.8%
Exchange-Traded Funds	15	15	6.8%	325	334	-2.5%	21	16.5%	5,270	16.1%
Structured Products	31	30	1.6%	642	692	-7.2%	41	15.8%	10,649	15.4%
Bonds	5	6	-12.3%	104	130	-20.0%	5	-13.1%	1,281	-13.5%
U.S. Cash Products (shares in millions)^5	1,794	2,007	-10.6%	37,682	44,148	-14.6%	2,283	-12.1%	575,223	-12.1%
NYSE Listed (Tape A) Issues ^4
Handled Volume ^5	1,277	1,496	-14.6%	26,821	32,908	-18.5%	1,607	-14.7%	404,910	-14.7%
Matched Volume ^6	1,212	1,419	-14.6%	25,445	31,224	-18.5%	1,523	-13.9%	383,863	-13.9%
Total NYSE Listed Consolidated Volume	3,623	4,050	-10.5%	76,086	89,092	-14.6%	4,370	-10.3%	1,101,268	-10.3%
Share of Total Consolidated Volume
Handled Volume ^5	35.3%	36.9%	-1.6%	35.3%	36.9%	-1.6%	36.8%	-1.9%	36.8%	-1.9%
Matched Volume ^6	33.4%	35.0%	-1.6%	33.4%	35.0%	-1.6%	34.9%	-1.5%	34.9%	-1.5%
NYSE Arca & Amex (Tape B) Listed Issues
Handled Volume ^5	295	266	10.8%	6,192	5,855	5.8%	381	-1.1%	96,040	-1.1%
Matched Volume ^6	263	240	9.6%	5,517	5,273	4.6%	343	-0.9%	86,460	-0.9%
Total NYSE Arca & Amex Listed Consolidated Volume	1,170	1,045	12.0%	24,580	22,998	6.9%	1,474	1.3%	371,409	1.3%
Share of Total Consolidated Volume
Handled Volume ^5	25.2%	25.5%	-0.3%	25.2%	25.5%	-0.3%	25.9%	-0.6%	25.9%	-0.6%
Matched Volume ^6	22.4%	22.9%	-0.5%	22.4%	22.9%	-0.5%	23.3%	-0.5%	23.3%	-0.5%
Nasdaq Listed (Tape C) Issues
Handled Volume ^5	222	245	-9.2%	4,669	5,386	-13.3%	295	-10.0%	74,274	-10.0%
Matched Volume ^6	189	211	-10.1%	3,979	4,636	-14.2%	254	-8.3%	63,941	-8.3%
Total Nasdaq Listed Consolidated Volume	1,615	1,688	-4.3%	33,911	37,140	-8.7%	2,022	-7.8%	509,421	-7.8%
Share of Total Consolidated Volume
Handled Volume ^5	13.8%	14.5%	-0.7%	13.8%	14.5%	-0.7%	14.6%	-0.4%	14.6%	-0.4%
Matched Volume ^6	11.7%	12.5%	-0.8%	11.7%	12.5%	-0.8%	12.6%	0.0%	12.6%	0.0%
Exchange-Traded Funds ^5,7
Handled Volume ^5	279	237	17.7%	5,854	5,209	12.4%	360	-2.5%	90,741	-2.5%
Matched Volume ^6	248	214	15.7%	5,202	4,710	10.4%	324	-2.6%	81,632	-2.6%
Total ETF Consolidated Volume	1,139	948	20.2%	23,917	20,852	14.7%	1,420	-0.4%	357,841	-0.4%
Share of Total Consolidated Volume
Handled Volume ^5	24.5%	25.0%	-0.5%	24.5%	25.0%	-0.5%	25.4%	-0.5%	25.4%	-0.5%
Matched Volume ^6	21.7%	22.6%	-0.9%	21.7%	22.6%	-0.9%	22.8%	-0.5%	22.8%	-0.5%

¹ Data includes currency products.

² Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.

³ Includes trading in U.S. equity options contracts, not equity-index options.

⁴ Includes all volume executed in NYSE Group crossing sessions.

⁵ Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.

⁶ Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.

⁷ Data included in previously identified categories.

^* ADVs calculated with the appropriate number of NYSE Liffe U.S. trading days.

Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.

All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.